Schneider National sees FY27 earnings upside from Cowan synergies, capacity discipline, and margin recovery after 2025. Read ...
Stock indices rallied despite limited CPI data last month; since then, small-caps and Dow are outperforming tech into early ...
AMD gains AI share as DC revenue hit $4.3B, MI300 adoption rises, MI400 targets cloud inference at premium valuation. Read ...
Rocket Lab won an $816M SDA contract, with space systems driving growth, validated tech, and a 79x EV/sales valuation. Read ...
Falling rents and looming tariff impacts may lift goods inflation, squeeze margins, and raise recession risk. Read more on ...
CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...
Oil trading below $60 pressures U.S. energy companies. Read more about supply risks from Venezuela, yet how that may not ...
A look at the bull run since it began in October 2022. This chart highlights the 94.8% gain in the S&P 500 from the October ...
Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair ...
Armanino Foods of Distinction rose 57.75%, with FY24 revenue up 9%, net income +63.6%, debt-free, strong dividend, and cash ...
Glencore merger talks could reshape mining, boosting copper exposure but facing major regulatory/execution risks. Learn more ...
Altria relies on cigarettes as vapes face bans, flavors grow and on! competes with ZYN, with low multiple and 7.5% dividend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results